About
Dr Sonntag is a veteran of the Life Sciences and Healthcare industries and currently serves as advisor to a number of industry-related for-profit and not-for-profit boards, including Unistraw, the Life Sciences Advisory Board of Johnston Blakely & Company, LLC, the Advisory Board of Utah Ventures and the Health Technology Center, a non-profit research and education organization that provides strategic information and resources to healthcare organizations about the future impact of technology in healthcare delivery. Most recently, Linda was Executive Chair of Cellgate, Inc. a company committed to developing innovative anti-proliferative drugs to target diseases characterized by uncontrolled cell division. Previously, Dr. Sonntag was a General Partner of Axiom Venture Partners, L.P., founded in April 1994 to invest primarily in medical/healthcare and media/communications areas. Dr. Sonntag was also CEO of SyStemix, Inc., (NASDAQ: STMX, now NYSE: NVS), and prior to SyStemix, Dr. Sonnta
Position in the VCSift Database
- • 243 investors hold the Board Member role in VCSift. Linda Sonntag is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Linda
Search Investors